the questions asked need to be very simple, on point, and with nil wiggle room; for example
1) who is responsible for marketing of FebriDx
2) who is responsible for selling FebriDx
3) why was the revenue for FebriDx sold in q1 so low
4) do you feel there should be any correlation between share price / market cap performance and management remuneration
5) aside from product selling, do you plan to keep Lumos in the provision of services business long term
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 2.9¢ | 2.7¢ | $21.83K | 783.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 373288 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 211609 | 7 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| LDX (ASX) Chart |